57 related articles for article (PubMed ID: 21291834)
1. The identification of occult cardiovascular disease through the use of a novel biomarker: a case report.
Bale B; Doneen A; Wegner M
J Clin Lipidol; 2009 Oct; 3(5):351-4. PubMed ID: 21291834
[No Abstract] [Full Text] [Related]
2. Genomics and cardiovascular drug development.
Plump AS; Lum PY
J Am Coll Cardiol; 2009 Mar; 53(13):1089-100. PubMed ID: 19324252
[TBL] [Abstract][Full Text] [Related]
3. Proteomic strategies for biomarker identification: progress and challenges.
Fung ET; Wright GL; Dalmasso EA
Curr Opin Mol Ther; 2000 Dec; 2(6):643-50. PubMed ID: 11249741
[TBL] [Abstract][Full Text] [Related]
4. Brief report: occult pseudoxanthoma elasticum in patients with premature cardiovascular disease.
Lebwohl M; Halperin J; Phelps RG
N Engl J Med; 1993 Oct; 329(17):1237-9. PubMed ID: 8413390
[No Abstract] [Full Text] [Related]
5. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease.
Puntmann VO
Postgrad Med J; 2009 Oct; 85(1008):538-45. PubMed ID: 19789193
[TBL] [Abstract][Full Text] [Related]
6. Biomarker identification in neurologic diseases: improving diagnostics and therapeutics.
Coon KD; Dunckley T; Stephan DA
Expert Rev Mol Diagn; 2004 May; 4(3):361-75. PubMed ID: 15137903
[TBL] [Abstract][Full Text] [Related]
7. Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar.
Welsh P; Packard CJ; Sattar N
Curr Opin Lipidol; 2008 Dec; 19(6):563-71. PubMed ID: 18957878
[TBL] [Abstract][Full Text] [Related]
8. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.
Sen S; McDonald SP; Coates PT; Bonder CS
Clin Sci (Lond); 2011 Apr; 120(7):263-83. PubMed ID: 21143202
[TBL] [Abstract][Full Text] [Related]
9. The role of lipoprotein-associated phospholipase A2 on cardiovascular disease risk assessment and plaque rupture: a clinical review.
Reddy KJ; Singh M; Bangit JR; Batsell RR
J Clin Lipidol; 2009 Apr; 3(2):85-93. PubMed ID: 21291797
[TBL] [Abstract][Full Text] [Related]
10. Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods.
Johnston O; Cassidy H; O'Connell S; O'Riordan A; Gallagher W; Maguire PB; Wynne K; Cagney G; Ryan MP; Conlon PJ; McMorrow T
Proteomics Clin Appl; 2011 Aug; 5(7-8):422-31. PubMed ID: 21751411
[TBL] [Abstract][Full Text] [Related]
11. Loss of NKX3-1 as a potential marker for an increased risk of occult lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Miyaguchi K; Uzawa N; Mogushi K; Takahashi K; Michikawa C; Nakata Y; Sumino J; Okada N; Mizushima H; Fukuoka Y; Tanaka H
Int J Oncol; 2012 Jun; 40(6):1907-14. PubMed ID: 22344708
[TBL] [Abstract][Full Text] [Related]
12. Occult retrocervical endometriosis. A case report.
Perry CP; Mena MV
J Reprod Med; 1995 Sep; 40(9):652-4. PubMed ID: 8576883
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.
Hollan I; Bottazzi B; Cuccovillo I; Førre ØT; Mikkelsen K; Saatvedt K; Almdahl SM; Mantovani A; Meroni PL;
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):378-85. PubMed ID: 20391484
[TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration.
Coscas F; Coscas G; Souied E; Tick S; Soubrane G
Am J Ophthalmol; 2007 Oct; 144(4):592-9. PubMed ID: 17698019
[TBL] [Abstract][Full Text] [Related]
15. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
[TBL] [Abstract][Full Text] [Related]
16. [Occult perineural cysts in a case of Von Recklinghausen disease. Report of a case].
Bonfanti MT; Fioretti MC; Rispoli GA; Rizzato R; Russo P; Uslenghi CM
Radiol Med; 1997; 93(1-2):148-50. PubMed ID: 9380857
[No Abstract] [Full Text] [Related]
17. Renin as a biomarker of cardiovascular disease in clinical practice.
Volpe M; Battistoni A; Chin D; Rubattu S; Tocci G
Nutr Metab Cardiovasc Dis; 2012 Apr; 22(4):312-7. PubMed ID: 22402063
[TBL] [Abstract][Full Text] [Related]
18. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
19. [Significance of the stool occult blood test in patients with thrombotic disease under treatment with low dose aspirin].
Hayashi S; Wakizaka A
Rinsho Ketsueki; 2005 Apr; 46(4):254-60. PubMed ID: 16444957
[TBL] [Abstract][Full Text] [Related]
20. Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope.
Quiroga JA; Castillo I; Llorente S; Bartolomé J; Barril G; Carreño V
J Hepatol; 2009 Feb; 50(2):256-63. PubMed ID: 19070391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
